Mankind Pharma Limited (MANKIND.NS)
INR 2385.8
(-3.22%)
INR 2385.8
(-3.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 42.19 Billion INR | 110.28% |
| 2022 | 33.88 Billion INR | -36.21% |
| 2021 | 53.11 Billion INR | 21.01% |
| 2020 | 43.89 Billion INR | 11.35% |
| 2019 | 39.41 Billion INR | 22.1% |
| 2018 | 32.28 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 13.39 Billion INR | -21.39% |
| 2023 Q1 | 17.58 Billion INR | 120.22% |
| 2023 Q2 | 18.83 Billion INR | 7.08% |
| 2023 Q3 | 17.79 Billion INR | -5.52% |
| 2023 Q4 | 17.03 Billion INR | -4.25% |
| 2023 FY | 71.25 Billion INR | 110.28% |
| 2022 Q1 | 14.24 Billion INR | 23.55% |
| 2022 FY | 33.88 Billion INR | -36.21% |
| 2022 Q4 | 7.98 Billion INR | -42.05% |
| 2022 Q2 | 16.19 Billion INR | 13.68% |
| 2022 Q3 | 13.78 Billion INR | -14.91% |
| 2021 FY | 53.11 Billion INR | 21.01% |
| 2021 Q4 | 11.53 Billion INR | 0.0% |
| 2020 FY | 43.89 Billion INR | 11.35% |
| 2019 FY | 39.41 Billion INR | 22.1% |
| 2018 FY | 32.28 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 2.09 Billion INR | -1915.102% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -336264.934% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -358.339% |
| FDC Limited | 6.58 Billion INR | -540.687% |
| Gufic Biosciences Limited | 4.07 Billion INR | -935.831% |
| Hikal Limited | 5.95 Billion INR | -608.241% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -920.923% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -794.174% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -6700.733% |
| Medico Remedies Limited | 262.14 Million INR | -15996.871% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -774.859% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -7874.695% |
| RPG Life Sciences Limited | 2.48 Billion INR | -1599.435% |
| Sequent Scientific Limited | 2.97 Billion INR | -1316.61% |
| Shilpa Medicare Limited | 3.56 Billion INR | -1084.677% |
| Sigachi Industries Limited | 2 Billion INR | -2007.443% |
| Themis Medicare Limited | 2.42 Billion INR | -1643.672% |
| Unichem Laboratories Limited | 4.86 Billion INR | -767.371% |
| Venus Remedies Limited | 2.18 Billion INR | -1833.349% |
| Wanbury Limited | 1.73 Billion INR | -2338.226% |
| ZIM Laboratories Limited | 1.26 Billion INR | -3228.328% |
| Lupin Limited | 125.09 Billion INR | 66.268% |
| Innova Captab Limited | 3.46 Billion INR | -1118.003% |
| Ind-Swift Limited | 2.17 Billion INR | -1842.296% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -2767.021% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 61.479% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 2648.281% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -578.114% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -6004.949% |
| Morepen Laboratories Limited | 6.16 Billion INR | -584.874% |
| Laurus Labs Limited | 15.44 Billion INR | -173.143% |
| Aarti Drugs Limited | 8.31 Billion INR | -407.407% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -239.395% |
| Alembic Limited | 1 Billion INR | -4119.247% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -57.565% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 39.145% |
| Vaishali Pharma Limited | 90.32 Million INR | -46617.869% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -623.623% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -6366.078% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -114.819% |
| Eris Lifesciences Limited | 10.42 Billion INR | -304.698% |
| Windlas Biotech Limited | 1.33 Billion INR | -3051.851% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 83.675% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -2136.353% |
| Orchid Pharma Limited | 2.32 Billion INR | -1718.598% |
| Albert David Limited | 1.4 Billion INR | -2896.76% |
| Hester Biosciences Limited | 1.27 Billion INR | -3213.075% |
| Sakar Healthcare Limited | 699.58 Million INR | -5931.716% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -923.385% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -629.875% |
| Divi's Laboratories Limited | 32.44 Billion INR | -30.077% |
| Neuland Laboratories Limited | 8.24 Billion INR | -411.613% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -176.54% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 66.299% |
| Wockhardt Limited | 7.72 Billion INR | -446.593% |
| Bal Pharma Limited | 770.19 Million INR | -5378.74% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 74.208% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1041.868% |
| Alkem Laboratories Limited | 52.29 Billion INR | 19.313% |
| Valiant Laboratories Limited | 138.02 Million INR | -30471.098% |
| Ajanta Pharma Limited | 21.06 Billion INR | -100.327% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -9232.456% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -37232.88% |
| Granules India Limited | 16.79 Billion INR | -151.183% |
| Medicamen Biotech Limited | 495.49 Million INR | -8416.126% |
| Ipca Laboratories Limited | 48.58 Billion INR | 13.147% |
| Brooks Laboratories Limited | 65.62 Million INR | -64205.061% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -7441.869% |
| Piramal Enterprises Limited | 8.04 Billion INR | -424.623% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 9.753% |
| NATCO Pharma Limited | 25.73 Billion INR | -63.961% |
| Suven Life Sciences Limited | -200.79 Million INR | 21114.747% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 38902.892% |
| Strides Pharma Science Limited | 14.38 Billion INR | -193.277% |
| Indoco Remedies Limited | 8.04 Billion INR | -424.642% |
| Alpa Laboratories Limited | 188.89 Million INR | -22238.855% |
| Lasa Supergenerics Limited | 121.02 Million INR | -34764.894% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -10690.245% |